Patent · US Active

IL-1β binding antibodies and fragments thereof

US7531166B2 · kind B2 · utility

23Cited by
20References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 21, 2006
Grant dateMay 12, 2009
Priority date
Expiry dateMar 1, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

An IL-1β binding antibody or IL-1β binding fragment thereof comprising the amino acid sequence of SEQ ID NO: 2, and related nucleic acids, vectors, cells, and compositions, as well as method of using same to treat or prevent a disease, and a method of preparing an affinity matured IL-1β binding polypeptide. IL-1β binding antibodies or IL-1β binding fragments thereof are provided which have desirable affinity and potency.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.